Press Releases
Acclaro Medical Announces FDA Clearance of UltraClear® Cold Ablative Fractional 2910 nm Fiber Laser for Treatment of Benign Pigmented Lesions and Vascular Dyschromia
Acclaro Medical, a medical technology company that specializes in developing and delivering trailblazing solutions for medical aesthetics and surgical practitioners worldwide, today announced clearance by the U.S. Food and Drug Administration (FDA) for a new indication of the Company's UltraClear® cold ablative fractional 2910 nm fiber laser. Learn More
UltraClear®, The World’s First Cold Fiber Laser, Wins Major Beauty Award for “Best Laser Treatment for All Skin Tones” – Second Year in a Row
Acclaro Medical announced that UltraClear® was awarded the "Best Laser Treatment for All Skin Tones - 2024" from NewBeauty Magazine. The win in this highly regarded and very popular publication is a repeat favorite for the second year in a row, having secured the coveted award for UltraClear laser in 2023. Learn More
UltraClear Laser Pioneers Comfort with Revolutionary Laser Technology
As technology continues to evolve, Acclaro Medical adapts to technological advancements, pushes boundaries, and fosters positive change in the aesthetic industry. Learn More
MellingMedical to Deliver Acclaro’s UltraClear Cold Fiber Laser Technology to Federal Health Facilities
MellingMedical today announced a new distribution relationship with Acclaro Medical, an emerging leader in energy-based non-invasive, aesthetic medical devices. Learn More
Acclaro Medical Unveils Rebranding of Flagship Product UltraClear Cold Fiber Laser, Paving the Way for Next-Level Innovation and Customer Engagement
Acclaro Medical, a trailblazer in the aesthetic medical laser sector, is pleased to announce the rebranding of its flagship product, UltraClear® Cold Fiber Laser. The strategic initiative marks an important milestone in the company's evolution, signaling a fresh chapter of growth filled with enhanced customer experiences, groundbreaking innovations, and significant Learn More
Acclaro Corporation Highlights Clinical Study Results of UltraClear™ Cold Ablative Fiber Laser for Skin Resurfacing at American Society of Laser Medicine and Surgery 2023 Annual Conference
Acclaro Corporation, a medical technology company that specializes in developing and delivering novel solutions that address the most challenging needs in the medical aesthetics and surgical fields, today announced that four podium talks will be presented at the American Society for Laser Medicine and Surgery (ASLMS) meeting being held in Learn More
World’s First Cold Ablative Fiber Laser for Anti-Aging UltraClear™ Technology Wins Major Beauty Award – 2023
Acclaro Medical Corporation, an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, is thrilled to announce it has been honored with the prestigious NewBeauty award for its game-changing "Cold Fiber" technology for resurfacing all skin tones. Learn More
World’s First FDA Approved Cold Ablative Fiber Laser Makes US Debut!
Acclaro Corporation Launches UltraClear™ at ASLMS 2022 in San Diego, CA Learn More